Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Harter, Patrick N ^a,b   Zinke, Jenny ^a   Scholz, Alexander ^a   Tichy, Julia ^a   Zachskorn, Cornelia ^a,b   Kvasnicka, Hans M ^a,b   Goeppert, Benjamin ^b,c   Delloye Bourgeois, Céline ^d   Hattingen, Elke ^a   Senft, Christian ^a   Steinbach, Joachim P ^a,b   Plate, Karl H ^a,b   Mehlen, Patrick ^d   Schulte, Dorothea ^a   Mittelbronn, Michel ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; NETRIN 1;

AGE; ARTICLE; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER SURVIVAL; CELL NUCLEUS; COHORT ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION;

BRAIN NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; NERVE GROWTH FACTORS; PROGNOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84898656795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092311     Document Type: Article

References (39)

1. Castets M, Broutier L, Molin Y, Brevet M, Chazot G, et al. (2012) DCC constrains tumour progression via its dependence receptor activity. Nature 482: 534-537. doi:10.1038/nature10708.
2. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, et al. (2004) Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431: 80-84. doi:10.1038/nature02788. (Pubitemid 39215111)
3. Dumartin L, Quemener C, Laklai H, Herbert J, Bicknell R, et al. (2010) Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells. Gastroenterology 138: 1595-606-1606.e1-8. doi:10.1053/j.gastro.2009.12.061.
4. Park KW, Crouse D, Lee M, Karnik SK, Sorensen LK, et al. (2004) The axonal attractant Netrin-1 is an angiogenic factor. Proc Natl Acad Sci USA 101: 16210-16215. doi:10.1073/pnas.0405984101. (Pubitemid 39552824)
5. Nguyen A, Cai H (2006) Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism. Proc Natl Acad Sci USA 103: 6530-6535. doi:10.1073/pnas.0511011103.
6. Fan Y, Shen F, Chen Y, Hao Q, Liu W, et al. (2008) Overexpression of netrin-1 induces neovascularization in the adult mouse brain. J Cereb Blood Flow Metab 28: 1543-1551. doi:10.1038/jcbfm.2008.39.
7. Castets M, Coissieux MM, Delloye-Bourgeois C, Bernard L, Delcros J-G, et al. (2009) Inhibition of endothelial cell apoptosis by netrin-1 during angiogenesis. Developmental Cell 16: 614-620. doi:10.1016/j.devcel.2009.02.006.
8. Bouvrée K, Larrivée B, Lv X, Yuan L, DeLafarge B, et al. (2008) Netrin-1 inhibits sprouting angiogenesis in developing avian embryos. Developmental Biology 318: 172-183. doi:10.1016/j.ydbio.2008.03.023.
9. Fitamant J, Guenebeaud C, Coissieux MM, Guix C, Treilleux I, et al. (2008) Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci USA 105: 4850-4855. doi:10.1073/pnas.0709810105. (Pubitemid 351753835)
10. Papanastasiou AD, Pampalakis G, Katsaros D, Sotiropoulou G (2011) Netrin-1 overexpression is predictive of ovarian malignancies. Oncotarget 2: 363-367.
11. Ramesh G, Berg A, Jayakumar C (2011) Plasma netrin-1 is a diagnostic biomarker of human cancers. Biomarkers 16: 172-180. doi:10.3109/1354750X.2010. 541564.
12. Kefeli U, Yildirim ME, Aydin D, Madenci OC, Yasar N, et al. (2012) Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers 17: 663-667. doi:10.3109/1354750X.2012. 709882.
13. Link B-C, Reichelt U, Schreiber M, Kaifi JT, Wachowiak R, et al. (2007) Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 14: 2591-2599. doi:10.1245/s10434-007-9469-6. (Pubitemid 47389585)
14. Delloye-Bourgeois C, Goldschneider D, Paradisi A, Therizols G, Belin S, et al. (2012) Nucleolar Localization of a Netrin-1 Isoform Enhances Tumor Cell Proliferation. Science Signaling 5: ra57-ra57. doi:10.1126/scisignal.2002456.
15. Coissieux MM, Tomsic J, Castets M, Hampel H, Tuupanen S, et al. (2011) Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer. Gastroenterology 141: 2039-2046. doi:10.1053/j.gastro.2011.08.041.
16. Hibi K, Mizukami H, Shirahata A, Goto T, Sakata M, et al. (2009) Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer. World J Surg 33: 1053-1057. doi:10.1007/s00268-008-9909-x.
17. Hibi K, Sakata M, Sakuraba K, Kitamura Y-H, Shirahata A, et al. (2010) Methylation of the DCC gene is lost in advanced gastric cancer. Anticancer Res 30: 107-109.
18. Krimpenfort P, Song J-Y, Proost N, Zevenhoven J, Jonkers J, et al. (2012) Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. Nature 482: 538-541. doi:10.1038/nature10790.
19. Lv D, Zhao W, Dong D, Qian X-P, Zhang Y, et al. (2011) Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma. Eur J Cancer 47: 2068-2076. doi:10.1016/j.ejca.2011.04.021.
20. Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, et al. (2009) Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst 101: 237-247. doi:10.1093/jnci/djn491.
21. Mille F, Llambi F, Guix C, Delloye-Bourgeois C, Guenebeaud C, et al. (2009) Interfering with multimerization of netrin-1 receptors triggers tumor cell death. Cell Death Differ 16: 1344-1351. doi:10.1038/cdd.2009.75.
22. Harter PN, Bunz B, Dietz K, Hoffmann K, Meyermann R, et al. (2010) Spatio-temporal deleted in colorectal cancer (DCC) and netrin-1 expression in human foetal brain development. Neuropathol Appl Neurobiol 36: 623-635. doi:10.1111/j.1365-2990.2010.01100.x.
23. Flannery TW, Suntharalingam M, Regine WF, Chin LS, Krasna MJ, et al. (2008) Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. Int J Radiat Oncol Biol Phys 72: 19-23. doi:10.1016/j.ijrobp.2007.12.031.
24. Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, et al. (2008) Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113: 1641-1648. doi:10.1002/cncr.23769.
25. Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, et al. (2012) A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro-Oncology 14: 910-918. doi:10.1093/neuonc/nos087.
26. Galicich JH, Sundaresan N, Thaler HT (1980) Surgical treatment of single brain metastasis. Evaluation of results by computerized tomography scanning. J Neurosurg 53: 63-67. doi:10.3171/jns.1980.53.1.0063. (Pubitemid 10071806)
27. Hammoud MA, McCutcheon IE, Elsouki R, Schoppa D, Patt YZ (1996) Colorectal carcinoma and brain metastasis: distribution, treatment, and survival. Ann Surg Oncol 3: 453-463. (Pubitemid 126728590)
28. Eichler AF, Kahle KT, Wang DL, Joshi VA, Willers H, et al. (2010) EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer. Neuro-Oncology 12: 1193-1199. doi:10.1093/neuonc/noq076.
29. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, et al. (2012) Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases. J Clin Oncol 30: 419-425. doi:10.1200/JCO.2011.38.0527.
30. Liccardi G, Hartley JA, Hochhauser D (2011) EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Research 71: 1103-1114. doi:10.1158/0008-5472.CAN-10-2384.
31. Lo H-W, Xia W, Wei Y, Ali-Seyed M, Huang S-F, et al. (2005) Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Research 65: 338-348. (Pubitemid 40070827)
32. Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, et al. (2005) Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res 11: 5856-5862. doi:10.1158/1078-0432.CCR- 05-0420. (Pubitemid 41170313)
33. Lin SY, Makino K, Xia W, Matin A, Wen Y, et al. (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biology 3: 802-808. doi:10.1038/ncb0901-802. (Pubitemid 32842685)
34. Wang S-C, Lien H-C, Xia W, Chen I-F, Lo H-W, et al. (2004) Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6: 251-261. doi:10.1016/j.ccr.2004.07.012. (Pubitemid 39222038)
35. Baldin V, Roman AM, Bosc-Bierne I, Amalric F, Bouche G (1990) Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. The EMBO Journal 9: 1511-1517.
36. Cao H, Lei ZM, Bian L, Rao CV (1995) Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinology 136: 3163-3172.
37. Paradisi A, Maisse C, Bernet A, Coissieux MM, Maccarrone M, et al. (2008) NF-κB Regulates Netrin-1 Expression and Affects the Conditional Tumor Suppressive Activity of the Netrin-1 Receptors. Gastroenterology 135: 1248-1257. doi:10.1053/j.gastro.2008.06.080.
38. Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94: 2698-2705. (Pubitemid 34478086)
39. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, et al. (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22: 2865-2872. doi:10.1200/JCO.2004.12.149. (Pubitemid 41079905)